Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 9058395)

1.

Current concepts of the pathophysiology of migraine.

Goadsby PJ.

Neurol Clin. 1997 Feb;15(1):27-42. Review.

PMID:
9058395
2.

Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan.

Goadsby PJ, Hargreaves RJ.

Neurology. 2000;55(9 Suppl 2):S8-14. Review.

PMID:
11089513
3.

Serotonin receptors and the acute attack of migraine.

Goadsby PJ.

Clin Neurosci. 1998;5(1):18-23. Review.

PMID:
9523053
4.

The biology of serotonin receptors: focus on migraine pathophysiology and treatment.

Hamel E.

Can J Neurol Sci. 1999 Nov;26 Suppl 3:S2-6. Review.

PMID:
10563226
5.

Serotonin in migraine: theories, animal models and emerging therapies.

Johnson KW, Phebus LA, Cohen ML.

Prog Drug Res. 1998;51:219-44. Review.

PMID:
9949863
6.

Efficacy of 5HT in migraine.

Buzzi MG.

Cephalalgia. 1999 Sep;19(7):625-6. No abstract available.

PMID:
10524654
8.

Serotonin and migraine.

Humphrey PP, Feniuk W, Perren MJ, Beresford IJ, Skingle M, Whalley ET.

Ann N Y Acad Sci. 1990;600:587-98; discussion 598-600. Review.

PMID:
2252337
9.

Serotonin receptor ligands: treatments of acute migraine and cluster headache.

Goadsby PJ.

Handb Exp Pharmacol. 2007;(177):129-43. Review.

PMID:
17087122
10.

The safety of triptans in the treatment of patients with migraine.

Jamieson DG.

Am J Med. 2002 Feb 1;112(2):135-40. Review.

PMID:
11835952
11.

[The role of agonists of serotonin receptor 5HT1B/D in pathogenesis and treatment of migraine attacks].

Stepień A.

Pol Merkur Lekarski. 1999 Jun;6(36):341-3. Review. Polish.

PMID:
10481551
12.

Pathophysiology of migraine--new insights.

Hargreaves RJ, Shepheard SL.

Can J Neurol Sci. 1999 Nov;26 Suppl 3:S12-9. Review.

PMID:
10563228
13.

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy.

De Vries P, Villalón CM, Saxena PR.

Eur J Pharmacol. 1999 Jun 30;375(1-3):61-74. Review. Erratum in: Eur J Pharmacol 1999 Nov 19;384(2-3):243-4.

PMID:
10443565
15.

Brain stem activation in spontaneous human migraine attacks.

Weiller C, May A, Limmroth V, Jüptner M, Kaube H, Schayck RV, Coenen HH, Diener HC.

Nat Med. 1995 Jul;1(7):658-60.

PMID:
7585147
16.

5HT1F- and 5HT7-receptor agonists for the treatment of migraines.

Agosti RM.

CNS Neurol Disord Drug Targets. 2007 Aug;6(4):235-7. Review.

PMID:
17691977
17.

Sumatriptan for the treatment of undifferentiated primary headaches in the ED.

Miner JR, Smith SW, Moore J, Biros M.

Am J Emerg Med. 2007 Jan;25(1):60-4.

PMID:
17157685
18.

5-HT(1)-like receptor agonists and the pathophysiology of migraine.

Saxena PR, Ferrari MD.

Trends Pharmacol Sci. 1989 May;10(5):200-4. Review.

PMID:
12722735
19.
20.

Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.

Millson DS, Tepper SJ, Rapoport AM.

Expert Opin Pharmacother. 2000 Mar;1(3):391-404. Review.

PMID:
11249525
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk